A. Christopher Boyd

1.6k total citations
21 papers, 509 citations indexed

About

A. Christopher Boyd is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, A. Christopher Boyd has authored 21 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in A. Christopher Boyd's work include Cystic Fibrosis Research Advances (12 papers), Energy Harvesting in Wireless Networks (5 papers) and RNA Interference and Gene Delivery (4 papers). A. Christopher Boyd is often cited by papers focused on Cystic Fibrosis Research Advances (12 papers), Energy Harvesting in Wireless Networks (5 papers) and RNA Interference and Gene Delivery (4 papers). A. Christopher Boyd collaborates with scholars based in United Kingdom, United States and Japan. A. Christopher Boyd's co-authors include David J. Porteous, J. Alastair Innes, Robert D. Gray, M. Imrie, Donald Noble, A P Greening, David J. Sherratt, Gordon MacGregor, Maria H Dewar and Uta Griesenbach and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

A. Christopher Boyd

21 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Christopher Boyd United Kingdom 11 234 231 106 61 43 21 509
B. Tümmler Germany 10 310 1.3× 182 0.8× 66 0.6× 26 0.4× 16 0.4× 19 505
Mónica Roxo‐Rosa Portugal 15 455 1.9× 251 1.1× 89 0.8× 31 0.5× 26 0.6× 24 670
M. Imrie United Kingdom 8 361 1.5× 281 1.2× 109 1.0× 105 1.7× 66 1.5× 12 683
Isabelle T. Crawford United States 7 335 1.4× 251 1.1× 51 0.5× 32 0.5× 47 1.1× 11 611
Dianne Kube United States 7 265 1.1× 229 1.0× 26 0.2× 34 0.6× 24 0.6× 9 481
Lee A. Davies United Kingdom 12 287 1.2× 230 1.0× 111 1.0× 45 0.7× 7 0.2× 17 515
Silke Hedtfeld Germany 10 229 1.0× 194 0.8× 49 0.5× 14 0.2× 8 0.2× 23 389
Thomas F. Scanlin United States 22 688 2.9× 424 1.8× 124 1.2× 92 1.5× 299 7.0× 51 1.2k
Matthew R. Markovetz United States 13 507 2.2× 172 0.7× 15 0.1× 85 1.4× 14 0.3× 34 690
Anna Plantinga United States 14 37 0.2× 344 1.5× 100 0.9× 48 0.8× 26 0.6× 31 568

Countries citing papers authored by A. Christopher Boyd

Since Specialization
Citations

This map shows the geographic impact of A. Christopher Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Christopher Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Christopher Boyd more than expected).

Fields of papers citing papers by A. Christopher Boyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Christopher Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Christopher Boyd. The network helps show where A. Christopher Boyd may publish in the future.

Co-authorship network of co-authors of A. Christopher Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of A. Christopher Boyd. A scholar is included among the top collaborators of A. Christopher Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Christopher Boyd. A. Christopher Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, Jane C., Deepika Polineni, A. Christopher Boyd, et al.. (2024). Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial. American Journal of Respiratory and Critical Care Medicine. 210(12). 1398–1408. 9 indexed citations
2.
Taylor‐Cousar, Jennifer L., A. Christopher Boyd, Eric W.F.W. Alton, & Deepika Polineni. (2023). Genetic therapies in cystic fibrosis. Current Opinion in Pulmonary Medicine. 29(6). 615–620. 6 indexed citations
3.
Boyd, A. Christopher, Shuling Guo, Lulu Huang, et al.. (2020). New approaches to genetic therapies for cystic fibrosis. Journal of Cystic Fibrosis. 19. S54–S59. 48 indexed citations
4.
Hyde, Stephen C., Lee A. Davies, Ian A. Pringle, et al.. (2015). 82. Scalable, Animal-Free, Suspension-Based Production of Siv Lentiviral Vectors. Molecular Therapy. 23. S35–S36. 1 indexed citations
5.
Alton, Eric W.F.W., A. Christopher Boyd, Shou‐Hsia Cheng, et al.. (2013). A PHASE 2B DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NON-VIRAL MEDIATED GENE THERAPY FOR CF. Oxford University Research Archive (ORA) (University of Oxford). 2 indexed citations
6.
Alton, Eric W.F.W., A. Christopher Boyd, Seng H. Cheng, et al.. (2013). A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis: Table 1. Thorax. 68(11). 1075–1077. 50 indexed citations
7.
Griesenbach, Uta, Makoto Inoue, R Farley, et al.. (2012). P95 Assessment of F/HN-pseudotyped Lentivirus as a Clinically Relevant Vector For Lung Gene Therapy. Thorax. 67(Suppl 2). A105.1–A105. 7 indexed citations
8.
Holder, Emma, Barbara Stevenson, Raymond Farley, et al.. (2009). Detection of CFTR transgene mRNA expression in respiratory epithelium isolated from the murine nasal cavity. The Journal of Gene Medicine. 12(1). 55–63. 2 indexed citations
9.
Gray, Robert D., Andrew Duncan, Donald Noble, et al.. (2009). Sputum Trace Metals Are Biomarkers of Inflammatory and Suppurative Lung Disease. CHEST Journal. 137(3). 635–641. 83 indexed citations
10.
Gray, Robert D., Gordon MacGregor, Donald Noble, et al.. (2008). Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases. American Journal of Respiratory and Critical Care Medicine. 178(5). 444–452. 145 indexed citations
11.
Griesenbach, Uta, Felix M. Munkonge, Stephanie Jones, et al.. (2008). Assessment of CFTR Function after Gene Transfer In Vitro and In Vivo. Methods in molecular biology. 433. 229–242. 10 indexed citations
12.
Davidson, Heather, Gerry McLachlan, A. Christopher Boyd, et al.. (2006). Human-Specific Cystic Fibrosis Transmembrane Conductance Regulator Antibodies Detect In Vivo Gene Transfer to Ovine Airways. American Journal of Respiratory Cell and Molecular Biology. 35(1). 72–83. 7 indexed citations
13.
Griesenbach, Uta & A. Christopher Boyd. (2005). Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy. Journal of Cystic Fibrosis. 4(2). 89–100. 16 indexed citations
14.
Nan, Xinsheng, et al.. (2004). Potent stimulation of gene expression by histone deacetylase inhibitors on transiently transfected DNA. Biochemical and Biophysical Research Communications. 324(1). 348–354. 15 indexed citations
15.
Walker, Wendy E., David J. Porteous, & A. Christopher Boyd. (2003). The effects of plasmid copy number and sequence context upon transfection efficiency. Journal of Controlled Release. 94(1). 245–252. 19 indexed citations
16.
Taylor, Martin S., et al.. (2000). Genomic Sequence Analysis of Fugu rubripes CFTR and Flanking Genes in a 60 kb Region Conserving Synteny with 800 kb of Human Chromosome 7. Genome Research. 10(8). 1194–1203. 23 indexed citations
17.
Davidson, Heather, Ann Doherty, Barbara Stevenson, A. Christopher Boyd, & David J. Porteous. (1999). Elimination of contaminantEscherichia coli chromosomal DNA from preparations of P1 artifical chromosome recombinants facilitates directed subcloning. Electrophoresis. 20(7). 1469–1475. 1 indexed citations
18.
Boyd, A. Christopher, Uwe Michaelis, Heather Davidson, et al.. (1999). Insertion of natural intron 6a‐6b into a human cDNA‐derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination. The Journal of Gene Medicine. 1(5). 312–321. 14 indexed citations
19.
Boyd, A. Christopher & David J. Porteous. (1997). PCR-Generated Crossover Linkers for Site-Directed Mutagenesis. BioTechniques. 23(5). 827–830. 1 indexed citations
20.
Boyd, A. Christopher & David J. Sherratt. (1995). The pCLIP plasmids: versatile cloning vectors based on the bacteriophage λ origin of replication. Gene. 153(1). 57–62. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Tümmler Breakdown of academic impact, for papers by Mónica Roxo‐Rosa Breakdown of academic impact, for papers by M. Imrie Breakdown of academic impact, for papers by Isabelle T. Crawford Breakdown of academic impact, for papers by Dianne Kube Breakdown of academic impact, for papers by Lee A. Davies Breakdown of academic impact, for papers by Silke Hedtfeld Breakdown of academic impact, for papers by Thomas F. Scanlin Breakdown of academic impact, for papers by Matthew R. Markovetz Breakdown of academic impact, for papers by Anna Plantinga
Rankless by CCL
2026